Furmark, Tomas

Moment-to-Moment Brain Signal Variability Reliably Predicts Psychiatric Treatment Outcome

Månsson, K. N. T., Waschke, L., Manzouri, A., Furmark, T., Fischer, H., & Garrett, D. D. (2022) · Biological Psychiatry

Functional Brain Connectivity StudiesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 49

Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial

Hjorth, O. R., Frick, A., Gingnell, M., Hoppe, J. M., Faria, V., Hultberg, S., Alaie, I., Månsson, K. N. T., Rosén, J., Reis, M., et al. (2021) · Translational Psychiatry

Neurotransmitter Receptor Influence on BehaviorAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 46

Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trial

Gingnell, M., Frick, A., Engman, J., Alaie, I., Björkstrand, J., Faria, V., Carlbring, P., Andersson, G., Reis, M., Larsson, E.-M., et al. (2016) · British Journal of Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesDigital Mental Health Interventions

Cited by 44

Genetic Polymorphisms in Monoamine Systems and Outcome of Cognitive Behavior Therapy for Social Anxiety Disorder

Andersson, E., Rück, C., Lavebratt, C., Hedman, E., Schalling, M., Lindefors, N., Eriksson, E., Carlbring, P., Andersson, G., & Furmark, T. (2013) · PLoS ONE

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 43

Think twice, it’s all right: Long lasting effects of disrupted reconsolidation on brain and behavior in human long-term fear

Björkstrand, J., Agren, T., Åhs, F., Frick, A., Larsson, E.-M., Hjorth, O., Furmark, T., & Fredrikson, M. (2017) · Behavioural Brain Research

Memory and Neural MechanismsMemory Processes and Influences

Cited by 42

Assessing Adolescent Anxiety in General Psychiatric Care: Diagnostic Accuracy of the Swedish Self-Report and Parent Versions of the Spence Children’s Anxiety Scale

Olofsdotter, S., Sonnby, K., Vadlin, S., Furmark, T., & Nilsson, K. W. (2016) · Assessment

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesChild and Adolescent Psychosocial and Emotional Development

Cited by 41

Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder

Faria, V., Åhs, F., Appel, L., Linnman, C., Bani, M., Bettica, P., Pich, E. M., Fredrikson, M., & Furmark, T. (2014) · The International Journal of Neuropsychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 37

Volume of subcortical brain regions in social anxiety disorder: mega-analytic results from 37 samples in the ENIGMA-Anxiety Working Group

Groenewold, N. A., Bas-Hoogendam, J. M., Amod, A. R., Laansma, M. A., Van Velzen, L. S., Aghajani, M., Hilbert, K., Oh, H., Salas, R., Jackowski, A. P., et al. (2023) · Molecular Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeural and Behavioral Psychology Studies

Cited by 36

Improvement in indices of cellular protection after psychological treatment for social anxiety disorder.

Månsson, K. N. T., Lindqvist, D., Yang, L. L., Svanborg, C., Isung, J., Nilsonne, G., Bergman-Nordgren, L., El Alaoui, S., Hedman-Lagerlöf, E., Kraepelien, M., et al. (2019) · Translational Psychiatry

Telomeres, Telomerase, and SenescenceAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 25

Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder

Frick, A., Åhs, F., Appel, L., Jonasson, M., Wahlstedt, K., Bani, M., Merlo Pich, E., Bettica, P., Långström, B., Lubberink, M., et al. (2016) · European Neuropsychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 22

Association between amygdala neurokinin-1 receptor availability and anxiety-related personality traits

Hoppe, J. M., Frick, A., Åhs, F., Linnman, C., Appel, L., Jonasson, M., Lubberink, M., Långström, B., Frans, Ö., von Knorring, L., et al. (2018) · Translational Psychiatry

Neuropeptides and Animal PhysiologyNeurotransmitter Receptor Influence on Behavior

Cited by 18

Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy

Hjorth, O., Frick, A., Gingnell, M., Engman, J., Björkstrand, J., Faria, V., Alaie, I., Carlbring, P., Andersson, G., Jonasson, M., et al. (2022) · Translational Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 13

Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters

Furmark, T., Wahlstedt, K., & Faria, V. (2025) · Frontiers in Psychology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPain Management and Placebo Effect

Cited by 1